Distribution of U.S. clinical and phase III pipeline 2013 by indication

Distribution of U.S. clinical and phase III pipeline in 2013, by indication

by Statista Research Department, last edited Jun 23, 2014
Distribution of U.S. clinical and phase III pipeline 2013 by indication This statistic depicts the distribution of U.S. clinical and phase III pipeline in 2013, by indication. Among all products in the clinical pipeline, some 37 percent were products concerning cancer. In phase III pipeline, the share of cancer products was 38 percent.
Show more

Distribution of U.S. clinical and phase III pipeline in 2013, by indication

Loading statistic...
Clinical pipelinePhase III pipeline
Cancer37%38%
Neurology13%10%
Infectious disease12%12%
Cardiovascular6%8%
Autoimmune6%4%
Metabolic and endocrine6%6%
Respiratory4%3%
Other16%19%
Clinical pipelinePhase III pipeline
Cancer37%38%
Neurology13%10%
Infectious disease12%12%
Cardiovascular6%8%
Autoimmune6%4%
Metabolic and endocrine6%6%
Respiratory4%3%
Other16%19%
Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Jun 23, 2014
This statistic depicts the distribution of U.S. clinical and phase III pipeline in 2013, by indication. Among all products in the clinical pipeline, some 37 percent were products concerning cancer. In phase III pipeline, the share of cancer products was 38 percent.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Clinical trials"
  • R&D overview
  • Top R&D companies
  • Clinical studies
  • Participation
  • Costs and market
  • Success rates
  • Approvals, launches, setbacks
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.